Company: MLTX
Filing Date: 2025-04-03
Form Type: 8-K
Source: 0001213900-25-028366
Chunk: 2

Company: MoonLake Immunotherapeutics
Filing Date: 2025-04-03
Form: 8-K
Item: Item 1.01
Chunk 2
---
 foreign subsidiaries, subject to certain exceptions.

The Loan and Security Agreement
contains customary covenants, including, without limitation, liquidity covenant and negative covenants that, subject to certain exceptions,
restrict indebtedness, liens, investments (including acquisitions), fundamental changes, asset sales and licensing and royalty transactions,
dividends, modifications to material agreements, payment of subordinated indebtedness, and other matters customarily restricted in such
agreements.

The Loan and Security Agreement
also contains certain events of default after which loans under the Credit Facility may be due and payable immediately, including payment
defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults
to certain other agreements, judgments against the Company and its subsidiaries, cessation of business and change of control.

The above description of the
Loan and Security Agreement and Credit Facility is a summary only and is qualified in its entirety by reference to the Loan and Security
Agreement, which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ending March 31, 2025.

Item 2.03 Creation of a Direct Financial
Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth
in Item 1.01 above is incorporated by reference into this Item 2.03.

Item 7.01 Regulation FD Disclosure.